Daniel Y Lu1, Ming Zhong2, Dmitriy N Feldman2. 1. Greenberg Division of Cardiology, Department of Medicine, From Weill Cornell Medical College, New York Presbyterian Hospital, 520 East 70th street, New York, NY, 10021, USA. dyl9002@nyp.org. 2. Greenberg Division of Cardiology, Department of Medicine, From Weill Cornell Medical College, New York Presbyterian Hospital, 520 East 70th street, New York, NY, 10021, USA.
Abstract
PURPOSE OF REVIEW: In ST-segment elevation myocardial infarction, urgent revascularization of the culprit coronary vessel and restoration of coronary flow is the goal of the initial management. However, obstructive non-culprit disease is frequently concomitantly found during initial angiography and portends a poor prognosis. Management of non-culprit lesions in ST-segment elevation myocardial infarction (STEMI) has been the subject of extensive debate. This review will examine the currently available evidence, with a specific focus on randomized clinical trials performed to date. RECENT FINDINGS: Although early observational data suggested better outcomes with culprit-only revascularization, more recent data from several randomized trials have suggested improved outcomes with complete multivessel revascularization, either during the index PCI procedure or as a staged procedure. Data from recent randomized controlled trials have suggested the superiority of complete or multivessel revascularization and have subsequently led to changes to the most recent iterations of STEMI guidelines. However, the optimal management and timing of revascularization of non-culprit lesions in STEMI remain controversial.
PURPOSE OF REVIEW: In ST-segment elevation myocardial infarction, urgent revascularization of the culprit coronary vessel and restoration of coronary flow is the goal of the initial management. However, obstructive non-culprit disease is frequently concomitantly found during initial angiography and portends a poor prognosis. Management of non-culprit lesions in ST-segment elevation myocardial infarction (STEMI) has been the subject of extensive debate. This review will examine the currently available evidence, with a specific focus on randomized clinical trials performed to date. RECENT FINDINGS: Although early observational data suggested better outcomes with culprit-only revascularization, more recent data from several randomized trials have suggested improved outcomes with complete multivessel revascularization, either during the index PCI procedure or as a staged procedure. Data from recent randomized controlled trials have suggested the superiority of complete or multivessel revascularization and have subsequently led to changes to the most recent iterations of STEMI guidelines. However, the optimal management and timing of revascularization of non-culprit lesions in STEMI remain controversial.
Authors: Colm G Hanratty; Yutaka Koyama; Helge H Rasmussen; Greg I C Nelson; Peter S Hansen; Michael R Ward Journal: J Am Coll Cardiol Date: 2002-09-04 Impact factor: 24.094
Authors: Timm Bauer; Uwe Zeymer; Matthias Hochadel; Helge Möllmann; Franz Weidinger; Ralf Zahn; Holger M Nef; Christian W Hamm; Jean Marco; Anselm K Gitt Journal: Int J Cardiol Date: 2011-12-20 Impact factor: 4.164
Authors: A Ghani; J-H E Dambrink; A W J van 't Hof; J P Ottervanger; A T M Gosselink; J C A Hoorntje Journal: Neth Heart J Date: 2012-09 Impact factor: 2.380
Authors: Zbigniew Kalarus; Radosław Lenarczyk; Jacek Kowalczyk; Oskar Kowalski; Mariusz Gasior; Tomasz Was; Tadeusz Zebik; Hubert Krupa; Piotr Chodór; Lech Poloński; Marian Zembala Journal: Am Heart J Date: 2007-02 Impact factor: 4.749
Authors: Ran Kornowski; Roxana Mehran; George Dangas; Eugenia Nikolsky; Abid Assali; Bimmer E Claessen; Bernard J Gersh; S Chiu Wong; Bernhard Witzenbichler; Giulio Guagliumi; Dariusz Dudek; Martin Fahy; Alexandra J Lansky; Gregg W Stone Journal: J Am Coll Cardiol Date: 2011-08-09 Impact factor: 24.094
Authors: Juan J Russo; George A Wells; Aun Yeong Chong; Derek Y So; Chris A Glover; Michael P V Froeschl; Benjamin Hibbert; Jean-François Marquis; Alexander Dick; Melissa Blondeau; Jordan Bernick; Marino Labinaz; Michel R Le May Journal: Am J Cardiol Date: 2015-07-29 Impact factor: 2.778
Authors: Paul Sorajja; Bernard J Gersh; David A Cox; Michael G McLaughlin; Peter Zimetbaum; Costantino Costantini; Thomas Stuckey; James E Tcheng; Roxana Mehran; Alexandra J Lansky; Cindy L Grines; Gregg W Stone Journal: Eur Heart J Date: 2007-06-07 Impact factor: 29.983
Authors: Anthony H Gershlick; Jamal Nasir Khan; Damian J Kelly; John P Greenwood; Thiagarajah Sasikaran; Nick Curzen; Daniel J Blackman; Miles Dalby; Kathryn L Fairbrother; Winston Banya; Duolao Wang; Marcus Flather; Simon L Hetherington; Andrew D Kelion; Suneel Talwar; Mark Gunning; Roger Hall; Howard Swanton; Gerry P McCann Journal: J Am Coll Cardiol Date: 2015-03-17 Impact factor: 24.094
Authors: Krishnaraj Sinhji Rathod; Marco Spagnolo; Mark K Elliott; Anne-Marie Beirne; Elliot J Smith; Rajiv Amersey; Charles Knight; Roshan Weerackody; Andreas Baumbach; Anthony Mathur; Daniel A Jones Journal: Clin Med Insights Cardiol Date: 2020-08-21